Last reviewed · How we verify
NCT07390019: FamCASP
Families Experiencing Cancer - Support to Prevent Cancer-related Illness
NA trial testing FamCASP in Cancer in 800 participants. Not yet recruiting.
30 December 2030
Quick facts
| Lead sponsor | Malmö University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 800 |
| Start date | 2 February 2026 |
| Primary completion | 30 December 2030 |
| Estimated completion | 30 December 2032 |
Drugs / interventions tested
- FamCASP
Conditions studied
- Cancer — all drugs for Cancer →
- Family Members — all drugs for Family Members →
- Support, Family — all drugs for Support, Family →
Sponsor
Malmö University
Who can join
18 and older, any sex, with Cancer or Family Members. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this planned project, we aim to evaluate the FamCASP model and the digital screening tool SCa-N as an intervention within routine cancer care. An expected outcome of FamCASP is an increase in family health as expressed in lower levels of psychological distress, improved coping strategies and family climate and a decrease in unmet needs as measured by family members' self-reports as well as their descriptions during interviews. Hence, the specific aims are to: I. Describe differences in psychological distress, coping strategies, family climate and unmet needs between baseline and follow-up in family members receiving support according to the FamCASP model in outpatient cancer clinics and to explore whether or not there are differences between family members receiving support and those who do not receive support. II. Describe family members' experiences of receiving support according to the FamCASP model. III. Describe family members' experiences of interacting with the digital tool.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07390019
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Malmö University trials
Trials by the same sponsor.
- NCT07344909 — Burning Mouth Syndrome: Effects of Occlusal Splint Therapy · NA · not yet recruiting
- NCT07095101 — ePROPP - eHealth for Preventing and Reducing Orofacial Pain in the Population · NA · not yet recruiting
- NCT07266701 — The General Aim is to Implement Clinical Assessment of Overload by Voluntary Bite Force Registration to Enable Future Si · enrolling by invitation
- NCT06833034 — Comparing a Novel Closed Exposure Technique to a Conventional Method for Palatally Impacted Maxillary Canines · NA · recruiting
- NCT06427889 — Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07390019 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Malmö University
- Last refreshed: 5 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07390019.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing